Stockreport

DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H...

DBV Technologies S.A. - American Depositary Shares  (DBVT) 
US:NASDAQ Investor Relations: dbv-technologies.com/en/investor-relations
PDF Châtillon, France, March 24, 2025 DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for Biologics License Application (BLA) for Viaskin® Pea [Read more]